FDA Person
FDAMatthew C. Watson
View detailed information about Matthew C. Watson, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 108 inspections of 101 companies, 2016–2026.
Inspections (108)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| February 11, 2026 | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | NAI | Human Cellular, Tissue, and Gene Therapies | #1304580 |
| September 24, 2025 | Jeffrey S. Dover, MD | Not classified | #1284686 | |
| September 15, 2025 | Pasi A. Janne, M.D., Ph.D. | NAI | Bioresearch Monitoring | #1283192 |
| July 31, 2025 | Katarzyna Jarus-Dziedzic MD, PhD | Not classified | #1281145 | |
| July 25, 2025 | Piotr Sobieraj M.D. | Not classified | #1280456 | |
| July 2, 2025 | Micro Medical Solutions, Inc. | VAI | Product Evaluation: Medical Devices | #1275080 |
| June 5, 2025 | Basil T. Darras, M.D. | NAI | Bioresearch Monitoring | #1273720 |
| May 16, 2025 | Boston University National Emerging Infectious Disease Laboratories | Not classified | #1270105 | |
| April 25, 2025 | Labcorp Bedford LLC. | Not classified | #1271033 | |
| April 15, 2025 | Jeremy Schmahmann, M.D. | NAI | Bioresearch Monitoring | #1269424 |
| March 24, 2025 | Andre Witkin, M.D. | Not classified | #1268437 | |
| January 29, 2025 | Canan Albayrak, M.D. | NAI | Bioresearch Monitoring | #1262810 |
| January 24, 2025 | Sernaz Topaloglu, M.D. | NAI | Bioresearch Monitoring | #1261488 |
| January 14, 2025 | Concord Biomedical Science and Emerging Technologies, Inc. | Not classified | #1262945 | |
| December 13, 2024 | Pfizer, Inc. | VAI | Bioresearch Monitoring: Human Drugs | #1256477 |
| December 4, 2024 | Partner Therapeutics, Inc. | NAI | Bioresearch Monitoring | #1257612 |
| November 15, 2024 | Suresh Maroli | Not classified | #1256485 | |
| November 14, 2024 | Intercept Pharmaceuticals, Inc. | NAI | Bioresearch Monitoring | #1257609 |
| October 18, 2024 | Thea Pharma, Inc. | NAI | Bioresearch Monitoring | #1256357 |
| October 1, 2024 | Perceptive Informatics LLC | NAI | Bioresearch Monitoring | #1252705 |
Documents (23)
- EIR · New England IRB · July 14, 2016
- EIR · Daniel J. DeAngelo, MD · April 16, 2021
- EIR · Karyopharm Therapeutics Inc. · February 28, 2020
- EIR · Jenis, Louis G., M.D. · December 7, 2011
- EIR · Covis Pharma GmBH · April 5, 2019
- EIR · Pfizer, Inc. · December 5, 2014
- 483 · Boston University National Emerging Infectious Disease Laboratories · May 16, 2025
- 483 · Lana M. Rifkin, M.D. · March 12, 2019
- 483 · Andrew A. Nierenberg, M.D. · February 21, 2020
- 483 · Christopher J. Hartnick, MD · June 28, 2019
- 483 · Deepak C. D'Souza, M.D. · May 20, 2022
- 483 · Jeffrey S. Dover, MD · September 20, 2021
- EIR · PAREXEL INTERNATIONAL, Corp · August 5, 2020
- EIR · Sarepta Therapeutics, Inc. · April 18, 2019
- 483 · Kadmon Corporation, LLC · December 8, 2020
- 483 · Elijah W. Stommel, M.D. · April 11, 2023
- 483 · Glenn Gandelman, M.D. · March 10, 2023
- 483 · Pfizer Inc. · September 30, 2014
- 483 · Aditya Bardia, M.D. · August 17, 2018
- EIR · Sesen Bio, Inc. · June 3, 2021
- EIR · Pfizer Inc. · September 30, 2014
- 483 · Pfizer Inc. · December 13, 2024
- 483 · Micro Medical Solutions, Inc. · July 2, 2025
Frequently inspected with (10)
Person Information
Name
Matthew C. Watson
Role
ISSUING OFFICER
ID: a1594b84-f65a-42f9-a06d-a68a49eb4b28
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.